Free Trial Information
BioCentury | Feb 13, 2021
Deals

Feb. 12 Quick Takes: NexImmune, Decibel rise in NASDAQ debuts; plus Sagimet’s $80M crossover, Forbion launches VectorY, Aurora Science leads InteRNA round and a SPAC for Sharecare

...million ($22.3 million) series B investment in Utrecht-based miRNA company InteRNA Technologies B.V.  Existing investors Waterman Ventures...
Read More
BioCentury | Jul 15, 2020
Emerging Company Profile

Glympse raises $47.6M to test biosensors that could improve on liver biopsies in NASH

...32 led the round, which included new investors Temasek, DNS Capital, New Leaf Venture Partners, Waterman Ventures...
...25 Funds raised: $75.3 million Investors: Section 32, Temasek, DNS Capital, New Leaf Venture Partners, Waterman Ventures...
Read More
Items per page:
1 - 2 of 2
BioCentury | Feb 13, 2021
Deals

Feb. 12 Quick Takes: NexImmune, Decibel rise in NASDAQ debuts; plus Sagimet’s $80M crossover, Forbion launches VectorY, Aurora Science leads InteRNA round and a SPAC for Sharecare

...million ($22.3 million) series B investment in Utrecht-based miRNA company InteRNA Technologies B.V.  Existing investors Waterman Ventures...
Read More
BioCentury | Jul 15, 2020
Emerging Company Profile

Glympse raises $47.6M to test biosensors that could improve on liver biopsies in NASH

...32 led the round, which included new investors Temasek, DNS Capital, New Leaf Venture Partners, Waterman Ventures...
...25 Funds raised: $75.3 million Investors: Section 32, Temasek, DNS Capital, New Leaf Venture Partners, Waterman Ventures...
Read More
Items per page:
1 - 2 of 2